SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001125345-21-000061
Filing Date
2021-04-29
Accepted
2021-04-29 16:02:52
Documents
16
Period of Report
2021-04-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgnx-20210429.htm   iXBRL 8-K 35442
2 EX-99.1 exhibit99-1earningspressre.htm EX-99.1 63010
8 macrogenics20logo_jpgormat1a.jpg GRAPHIC 139164
  Complete submission text file 0001125345-21-000061.txt   442185

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20210429.xsd EX-101.SCH 2420
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgnx-20210429_cal.xml EX-101.CAL 708
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgnx-20210429_def.xml EX-101.DEF 1641
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20210429_lab.xml EX-101.LAB 23970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20210429_pre.xml EX-101.PRE 12644
9 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20210429_htm.xml XML 10856
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 21870370
SIC: 2834 Pharmaceutical Preparations